BOYS MARK LAURENCE,BRADLEY MICHAEL F.,DELISLE ROBERT KIRK,HENNINGS D. DAVID,KENNEDY APRIL L.,MARMSATER FREDRIK P.,MEDINA MATTHEW DAVID,MUNSON MARK C.,RAST BRYSON,RIZZI JAMES P.,RODRIGUEZ MARTHA E.,TOP,BOYS Mark Laurence,BRADLEY Michael F.,DELISLE Robert Kirk,HENNINGS D. David,KENNEDY April L.,MARMSATER FRED
申请号：
SI201030706
公开号：
SI2516433T1
申请日:
2010.12.20
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.
